Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection
Clinical trial NCT01118663 · TERMINATED
Trial details
- NCT number
- NCT01118663
- Sponsor
- Cumberland Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.